|
1
|
Cohen A, Kamanda-Kosseh M, Recker RR,
Lappe JM, Dempster DW, Zhou H, Cremers S, Bucovsky M, Stubby J and
Shane E: Bone density after teriparatide discontinuation in
premenopausal idiopathic osteoporosis. J Clin Endocrinol Metab.
100:4208–4214. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nishiyama KK, Cohen A, Young P, Wang J,
Lappe JM, Guo XE, Dempster DW, Recker RR and Shane E: Teriparatide
increases strength of the peripheral skeleton in premenopausal
women with idiopathic osteoporosis: A pilot HR-pQCT study. J Clin
Endocrinol Metab. 99:2418–2425. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Frediani B, Bertoldi I, Pierguidi S,
Nicosia A, Picerno V, Filippou G, Cantarini L and Galeazzi M:
Improved efficacy of intramuscular weekly administration of
clodronate 200 mg (100 mg twice weekly) compared with 100 mg (once
weekly) for increasing bone mineral density in postmenopausal
osteoporosis. Clin Drug Investig. 33:193–198. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Leslie WD, Miller N, Rogala L and
Bernstein CN: Body mass and composition affect bone density in
recently diagnosed inflammatory bowel disease: The Manitoba IBD
Cohort Study. Inflamm Bowel Dis. 15:39–46. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jiang Y, Gou H, Wang S, Zhu J, Tian S and
Yu L: Effect of pulsed electromagnetic field on bone formation and
lipid metabolism of glucocorticoid-induced osteoporosis rats
through canonical Wnt signaling pathway. Evid Based Complement
Alternat Med. 2016:49270352016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hampson G, Edwards S, Conroy S, Blake GM,
Fogelman I and Frost ML: The relationship between inhibitors of the
Wnt signalling pathway (Dickkopf-1(DKK1) and sclerostin), bone
mineral density, vascular calcification and arterial stiffness in
post-menopausal women. Bone. 56:42–47. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Colaianni G, Brunetti G, Faienza MF,
Colucci S and Grano M: Osteoporosis and obesity: Role of Wnt
pathway in human and murine models. World J Orthop. 5:242–246.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Meng J, Ma X, Wang N, Jia M, Bi L, Wang Y,
Li M, Zhang H, Xue X, Hou Z, et al: Activation of GLP-1 receptor
promotes bone marrow stromal cell osteogenic differentiation
through β-catenin. Stem Cell Reports. 6:579–591. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang JF, Li G, Chan CY, Meng CL, Lin MC,
Chen YC, He ML, Leung PC and Kung HF: Flavonoids of Herba Epimedii
regulate osteogenesis of human mesenchymal stem cells through BMP
and Wnt/beta-catenin signaling pathway. Mol Cell Endocrinol.
314:70–74. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liou SF, Hsu JH, Chu HC, Lin HH, Chen IJ
and Yeh JL: KMUP-1 promotes osteoblast differentiation through cAMP
and cGMP pathways and signaling of BMP-2/Smad1/5/8 and
Wnt/β-catenin. J Cell Physiol. 230:2038–2048. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Renaud J, Nabavi SF, Daglia M, Nabavi SM
and Martinoli MG: Epigallocatechin-3-gallate, a promising molecule
for parkinson's disease? Rejuvenation Res. 18:257–269. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pae M and Wu D: Immunomodulating effects
of epigallocatechin-3-gallate from green tea: Mechanisms and
applications. Food Funct. 4:1287–1303. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Peter B, Bosze S and Horvath R:
Biophysical characteristics of proteins and living cells exposed to
the green tea polyphenol epigallocatechin-3-gallate (EGCg): Review
of recent advances from molecular mechanisms to nanomedicine and
clinical trials. Eur Biophys J. 46:1–24. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Oliveira MR, Nabavi SF, Daglia M,
Rastrelli L and Nabavi SM: Epigallocatechin gallate and
mitochondria-A story of life and death. Pharmacol Res. 104:70–85.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li X, Liu Y, Shi W, Xu H, Hu H, Dong Z,
Zhu G, Sun Y, Liu B, Gao H, et al: Droplet digital PCR improved the
EGFR mutation diagnosis with pleural fluid samples in
non-small-cell lung cancer patients. Clin Chim Acta. 471:177–184.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Feagan BG, Sandborn WJ, Gasink C,
Jacobstein D, Lang Y, Friedman JR, Blank MA, Johanns J, Gao LL,
Miao Y, et al: Ustekinumab as induction and maintenance therapy for
Crohn's disease. N Engl J Med. 375:1946–1960. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Halse J, Greenspan S, Cosman F, Ellis G,
Santora A, Leung A, Heyden N, Samanta S, Doleckyj S, Rosenberg E
and Denker AE: A phase 2, randomized, placebo-controlled,
dose-ranging study of the calcium-sensing receptor antagonist
MK-5442 in the treatment of postmenopausal women with osteoporosis.
J Clin Endocrinol Metab. 99:E2207–E2215. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu HF, He HC, Yang L, Yang ZY, Yao K, Wu
YC, Yang XB and He CQ: Pulsed electromagnetic fields for
postmenopausal osteoporosis and concomitant lumbar osteoarthritis
in southwest China using proximal femur bone mineral density as the
primary endpoint: Study protocol for a randomized controlled trial.
Trials. 16:2652015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yan Z, Guo Y, Wang Y, Li Y and Wang J:
MicroRNA profiles of BMSCs induced into osteoblasts with
osteoinductive medium. Exp Ther Med. 15:2589–2596. 2018.PubMed/NCBI
|
|
21
|
Marupanthorn K, Tantrawatpan C, Kheolamai
P, Tantikanlayaporn D and Manochantr S: Bone morphogenetic
protein-2 enhances the osteogenic differentiation capacity of
mesenchymal stromal cells derived from human bone marrow and
umbilical cord. Int J Mol Med. 39:654–662. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ge W, Shi L, Zhou Y, Liu Y, Ma GE, Jiang
Y, Xu Y, Zhang X and Feng H: Inhibition of osteogenic
differentiation of human adipose-derived stromal cells by
retinoblastoma binding protein 2 repression of RUNX2-activated
transcription. Stem Cells. 29:1112–1125. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ge C, Cawthorn WP, Li Y, Zhao G,
Macdougald OA and Franceschi RT: Reciprocal control of osteogenic
and adipogenic differentiation by ERK/MAP kinase phosphorylation of
Runx2 and PPARγ transcription factors. J Cell Physiol. 231:587–596.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hasegawa T, Oizumi K, Yoshiko Y, Tanne K,
Maeda N and Aubin JE: The PPARγ-selective ligand BRL-49653
differentially regulates the fate choices of rat calvaria versus
rat bone marrow stromal cell populations. BMC Dev Biol. 8:712008.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Duque G, Li W, Vidal C, Bermeo S, Rivas D
and Henderson J: Pharmacological inhibition of PPARγ increases
osteoblastogenesis and bone mass in male C57BL/6 mice. J Bone Miner
Res. 28:639–648. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lee H, Bae S and Yoon Y: The
anti-adipogenic effects of (−)epigallocatechin gallate are
dependent on the WNT/β-catenin pathway. J Nutr Biochem.
24:1232–1240. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xu S, Zhang Y, Liu B, Li K, Huang B, Yan
B, Zhang Z, Liang K, Jia C, Lin J, et al: Activation of mTORC1 in B
lymphocytes promotes osteoclast formation via regulation of
β-catenin and RANKL/OPG. J Bone Miner Res. 31:1320–1333. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang F, Wang Y, Zhao Y, Zhan Q, Yu P, Wang
J and Xue C: Sialoglycoprotein isolated from eggs of carassius
auratus ameliorates osteoporosis: An effect associated with
regulation of the Wnt/β-catenin pathway in rodents. J Agric Food
Chem. 64:2875–2882. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zheng X, Wu G, Nie Y and Lin Y:
Electroacupuncture at the governor vessel and bladder meridian
acupoints improves postmenopausal osteoporosis through
osteoprotegerin/RANKL/RANK and Wnt/β-catenin signaling pathways.
Exp Ther Med. 10:541–548. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yun HM, Park KR, Quang TH, Oh H, Hong JT,
Kim YC and Kim EC: 2,4,5-Trimethoxyldalbergiquinol promotes
osteoblastic differentiation and mineralization via the BMP and
Wnt/β-catenin pathway. Cell Death Dis. 6:e18192015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Fujita M, Urano T, Horie K, Ikeda K,
Tsukui T, Fukuoka H, Tsutsumi O, Ouchi Y and Inoue S: Estrogen
activates cyclin-dependent kinases 4 and 6 through induction of
cyclin D in rat primary osteoblasts. Biochem Biophys Res Commun.
299:222–228. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hosking SM, Dobbins AG, Pasco JA and
Brennan SL: Knowledge change regarding osteoporosis prevention:
Translating recommended guidelines into user-friendly messages
within a community forum. BMC Res Notes. 8:332015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang D, Wang Y, Xu S, Wang F, Wang B, Han
K, Sun D and Li L: Epigallocatechin-3-gallate protects against
hydrogen peroxide-induced inhibition of osteogenic differentiation
of human bone marrow-derived mesenchymal stem cells. Stem Cells
Int. 2016:75327982016. View Article : Google Scholar : PubMed/NCBI
|
